Caffeine, calcium, and Eaton-Lambert syndrome.
D000109:Acetylcholine / Q000378:metabolism; D000200:Action Potentials; D000293:Adolescent; D000328:Adult; D000368:Aged; D000924:Anticholesteremic Agents / Q000627:therapeutic use; D001984:Bronchial Neoplasms / Q000150:complications*; D002110:Caffeine / Q000627:therapeutic use*; D002118:Calcium / Q000627:therapeutic use*; D002277:Carcinoma / Q000150:complications; D004558:Electric Stimulation; D005071:Evoked Potentials; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D009046:Motor Neurons / Q000187:drug effects; D009135:Muscular Diseases / Q000188:drug therapy*; D009157:Myasthenia Gravis / Q000188:drug therapy; D009435:Synaptic Transmission / Q000187:drug effects; D013572:Synaptic Vesicles / Q000378:metabolism; D013960:Thyroid Function Tests; D014459:Ulnar Nerve
D000924:Anticholesteremic Agents; D002110:Caffeine; D000109:Acetylcholine; D002118:Calcium